Holen Sie sich die Stockscreener-App
3.17
0.63%
0.02
Handel nachbörslich:
3.17
Schlusskurs vom Vortag:
$3.15
Offen:
$3.16
24-Stunden-Volumen:
2.80M
Relative Volume:
0.78
Marktkapitalisierung:
$485.08M
Einnahmen:
$2.80M
Nettoeinkommen (Verlust:
$-115.18M
KGV:
-3.7413
EPS:
-0.8473
Netto-Cashflow:
$-94.03M
1W Leistung:
+6.02%
1M Leistung:
+32.64%
6M Leistung:
-36.60%
1J Leistung:
+1.60%
1-Tages-Spanne:
$3.08
$3.19
1-Wochen-Bereich:
$2.86
$3.19
52-Wochen-Spanne:
$2.24
$5.228
Absci Corp Stock (ABSI) Company Profile
Firmenname
Absci Corp
Sektor
Branche
Telefon
(360) 949-1041
Adresse
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
3.17 | 482.02M | 2.80M | -115.18M | -94.03M | -0.8473 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-02 | Eingeleitet | JP Morgan | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-01-22 | Eingeleitet | Needham | Buy |
| 2024-10-02 | Eingeleitet | Guggenheim | Buy |
| 2024-07-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Eingeleitet | Truist | Buy |
| 2022-03-02 | Fortgesetzt | Cowen | Market Perform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-11-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | BofA Securities | Neutral |
| 2021-08-16 | Eingeleitet | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-16 | Eingeleitet | Stifel | Hold |
Alle ansehen
Absci Corp Aktie (ABSI) Neueste Nachrichten
Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating - 富途牛牛
Absci, DigitalOcean and other big stocks moving lower in Wednesday's pre-market session - MSN
Redmile funds cut Absci (ABSI) holdings below 5% after share sale - Stock Titan
Portland InnoAbsci's move into generative AI | Why former Hydro Flask CEO joined Puffin - The Business Journals
Absci Corporation (NASDAQ:ABSI) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Absci Stock (ABSI) Opinions on Q4 Earnings and ABS-201 Trial Progress - Quiver Quantitative
ABSI Forecast, Price Target & Analyst Ratings | ABSCI CORP (NASDAQ:ABSI) - ChartMill
ABSI|Absci Corp|Price:2.990|Chg%:0.07 - TradingKey
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference - Yahoo Finance
Absci: Compelling AI Biotech Story, but Weak Fundamentals and Bearish Structure - Investing.com
Highs Report: Can Absci Corporation lead its sector in growth2026 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and RenovoRx (RNXT) - The Globe and Mail
JonesTrading Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛
Update Recap: Is Absci Corporation a top pick in the sectorWeekly Trade Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Is now the right time to enter Absci CorporationQuarterly Growth Report & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Targets Report: Will Absci Corporation benefit from government policy2026 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
Insider Trends: Will Absci Corporation benefit from government policy2026 Breakouts & Safe Entry Trade Signal Reports - baoquankhu1.vn
Absci Corp. Earnings Call: Betting on ABS-201 - TipRanks
Redmile Group (ABSI) reports 5.4% Absci stake as share count rises - Stock Titan
Absci, DigitalOcean And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
Vanguard affiliates to report separately as ABSI holdings shift (ABSI) - Stock Titan
Here's Why We're Watching Absci's (NASDAQ:ABSI) Cash Burn Situation - finance.yahoo.com
What is HC Wainwright's Forecast for Absci FY2030 Earnings? - marketbeat.com
Absci price target lowered to $4.20 from $4.32 at Morgan Stanley - TipRanks
A Quick Look at Today's Ratings for Absci Corp(ABSI.US), With a Forecast Between $4.2 to $8 - 富途牛牛
Absci Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Absci (NASDAQ:ABSI) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Needham Reiterates Buy Rating on ABSI with Price Target of $7.00 - GuruFocus
Absci Shares Fall on Wider 4Q Loss, Lower Revenue - news.futunn.com
Why Blaize Holdings Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket - Benzinga
Absci’s AI-Native Integrated Drug Creation Platform: Advancing Antibody Therapeutics and Biopharma Innovation - Minichart
Absci Reports Positive ABS-201 Clinical Progress, Strong Financials, and Advances AI-Designed Therapeutics Pipeline in 2025 Results - Minichart
Absci Corp (ABSI) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience By GuruFocus - Investing.com Canada
TD Cowen Maintains Absci Corp(ABSI.US) With Buy Rating - Moomoo
Absci reports Q4 EPS (20c), consensus (17c) - TipRanks
Absci Corporation (ABSI) reports Q4 loss, misses revenue estimates - MSN
Absci Corp’s 2025 Q4 Call: FDA Delays, Oncology Partnership Shifts, and ABS-201 Timeline Contradictions - Bitget
Absci Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Absci’s Q4 2025 earnings miss forecasts, stock dips - Investing.com
Absci Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Absci Corp. (NASDAQ:ABSI) Reports Mixed Q4 Results Amid Clinical Progress - ChartMill
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Absci (NASDAQ: ABSI) deepens 2025 loss while pushing ABS-201 toward key data - Stock Titan
Absci earnings missed by $0.02, revenue fell short of estimates - Investing.com
Absci (NASDAQ:ABSI) Announces Quarterly Earnings Results - MarketBeat
Absci shares slip nearly 4% on Q4 revenue miss, wider loss than expected - Investing.com
Absci 10-K: Partner revenue $2.8M, Net loss $115.2M, EPS $(0.84) - TradingView
ABSCI ($ABSI) Releases Q4 2025 Earnings - Quiver Quantitative
Finanzdaten der Absci Corp-Aktie (ABSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):